Caring Brands (CABR) Net Income towards Common Stockholders (2024 - 2026)
Caring Brands' (CABR) quarterly Net Income towards Common Stockholders came in at -$3.9 million in Q1 2026, down 615.16% year-on-year from $747934.9 in Q1 2025, and down 3.13% quarter-over-quarter from -$3.7 million in Q4 2025.
Caring Brands (CABR) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
Caring Brands' Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at -$3.9 million for Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 615.16% year-over-year to -$3.9 million in Q1 2026; TTM through Mar 2026 was -$9.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$7.4 million, down 2740.12% from the prior year.
- Net Income towards Common Stockholders declined to -$3.9 million in Q1 2026 per CABR's latest filing, from -$3.7 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$428906.0 in Q3 2024 and bottomed at -$3.9 million in Q1 2026.
- The 3-year median for Net Income towards Common Stockholders is -$1.3 million (2024), against an average of -$1.8 million.
- Across the five-year window, Net Income towards Common Stockholders slumped 283.88% in 2025 and tumbled 615.16% in 2026, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$862791.0 in 2024, then slumped by 333.02% to -$3.7 million in 2025, then declined by 3.13% to -$3.9 million in 2026.
- Per Business Quant, the three latest CABR Net Income towards Common Stockholders figures stand at -$3.9 million (Q1 2026), -$3.7 million (Q4 2025), and -$1.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Caring Brands | 20.66 Mn | 18.63 Mn | - | -3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.85 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -538,770.00 |
| Dec 31, 2024 | -862,791.00 |
| Sep 30, 2024 | -428,906.00 |